Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD).

Dunn W, Sanyal AJ, Brunt EM, Unalp-Arida A, Donohue M, McCullough AJ, Schwimmer JB.

J Hepatol. 2012 Aug;57(2):384-91. doi: 10.1016/j.jhep.2012.03.024. Epub 2012 Apr 17.

2.

Effect of lifetime alcohol consumption on the histological severity of non-alcoholic fatty liver disease.

Kwon HK, Greenson JK, Conjeevaram HS.

Liver Int. 2014 Jan;34(1):129-35. doi: 10.1111/liv.12230. Epub 2013 Jun 28.

3.

Modest alcohol consumption and carotid plaques or carotid artery stenosis in men with non-alcoholic fatty liver disease.

Sinn DH, Gwak GY, Cho J, Son HJ, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW, Yoo BC.

Atherosclerosis. 2014 Jun;234(2):270-5. doi: 10.1016/j.atherosclerosis.2014.03.001. Epub 2014 Mar 21.

PMID:
24704629
4.

Modest wine drinking and decreased prevalence of suspected nonalcoholic fatty liver disease.

Dunn W, Xu R, Schwimmer JB.

Hepatology. 2008 Jun;47(6):1947-54. doi: 10.1002/hep.22292.

PMID:
18454505
5.

Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography.

Wong VW, Chu WC, Wong GL, Chan RS, Chim AM, Ong A, Yeung DK, Yiu KK, Chu SH, Woo J, Chan FK, Chan HL.

Gut. 2012 Mar;61(3):409-15. doi: 10.1136/gutjnl-2011-300342. Epub 2011 Aug 16.

PMID:
21846782
6.

Characteristics and diagnosis of NAFLD/NASH.

Hashimoto E, Taniai M, Tokushige K.

J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:64-70. doi: 10.1111/jgh.12271. Review.

PMID:
24251707
7.

Light alcohol consumption plays a protective role against non-alcoholic fatty liver disease in Japanese men with metabolic syndrome.

Sogabe M, Okahisa T, Taniguchi T, Tomonari T, Tanaka T, Tanaka H, Nakasono M, Takayama T.

Liver Int. 2015 Jun;35(6):1707-14. doi: 10.1111/liv.12754. Epub 2015 Jan 21.

PMID:
25438866
8.

Low to moderate lifetime alcohol consumption is associated with less advanced stages of fibrosis in non-alcoholic fatty liver disease.

Hagström H, Nasr P, Ekstedt M, Kechagias S, Önnerhag K, Nilsson E, Rorsman F, Sheikhi R, Marschall HU, Hultcrantz R, Stål P.

Scand J Gastroenterol. 2017 Feb;52(2):159-165. doi: 10.1080/00365521.2016.1239759. Epub 2016 Oct 6.

PMID:
27650916
9.

Bacterial endotoxin and non-alcoholic fatty liver disease in the general population: a prospective cohort study.

Wong VW, Wong GL, Chan HY, Yeung DK, Chan RS, Chim AM, Chan CK, Tse YK, Woo J, Chu WC, Chan HL.

Aliment Pharmacol Ther. 2015 Sep;42(6):731-40. doi: 10.1111/apt.13327. Epub 2015 Jul 23.

10.

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).

Hossain N, Stepanova M, Afendy A, Nader F, Younossi Y, Rafiq N, Goodman Z, Younossi ZM.

Scand J Gastroenterol. 2011 Apr;46(4):479-84. doi: 10.3109/00365521.2010.539251. Epub 2010 Nov 30.

PMID:
21114431
11.

Independent and joint effects of moderate alcohol consumption and smoking on the risks of non-alcoholic fatty liver disease in elderly Chinese men.

Liu P, Xu Y, Tang Y, Du M, Yu X, Sun J, Xiao L, He M, Wei S, Yuan J, Wang Y, Liang Y, Wu T, Miao X, Yao P.

PLoS One. 2017 Jul 20;12(7):e0181497. doi: 10.1371/journal.pone.0181497. eCollection 2017.

12.

Prevalence and risk factors for biopsy-proven non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in a prospective cohort of adult patients with gallstones.

García-Monzón C, Vargas-Castrillón J, Porrero JL, Alonso MT, Bonachía O, Castillo MJ, Marcos A, Quirós E, Ramos B, Sánchez-Cabezudo C, Villar S, Sáez A, Rodríguez de Cía J, del Pozo E, Vega-Piris L, Soto-Fernández S, Lo Iacono O, Miquilena-Colina ME.

Liver Int. 2015 Aug;35(8):1983-91. doi: 10.1111/liv.12813. Epub 2015 Mar 5.

PMID:
25708133
13.

Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery.

Morita S, Neto Dde S, Morita FH, Morita NK, Lobo SM.

Obes Surg. 2015 Dec;25(12):2335-43. doi: 10.1007/s11695-015-1696-5.

PMID:
25920616
14.
15.

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement.

Athyros VG, Alexandrides TK, Bilianou H, Cholongitas E, Doumas M, Ganotakis ES, Goudevenos J, Elisaf MS, Germanidis G, Giouleme O, Karagiannis A, Karvounis C, Katsiki N, Kotsis V, Kountouras J, Liberopoulos E, Pitsavos C, Polyzos S, Rallidis LS, Richter D, Tsapas AG, Tselepis AD, Tsioufis K, Tziomalos K, Tzotzas T, Vasiliadis TG, Vlachopoulos C, Mikhailidis DP, Mantzoros C.

Metabolism. 2017 Jun;71:17-32. doi: 10.1016/j.metabol.2017.02.014. Epub 2017 Mar 4. Review.

PMID:
28521870
16.

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease.

Kwak MS, Kim D, Chung GE, Kang SJ, Park MJ, Kim YJ, Yoon JH, Lee HS.

Clin Mol Hepatol. 2012 Dec;18(4):383-90. doi: 10.3350/cmh.2012.18.4.383. Epub 2012 Dec 21.

17.

Physical activity recommendations, exercise intensity, and histological severity of nonalcoholic fatty liver disease.

Kistler KD, Brunt EM, Clark JM, Diehl AM, Sallis JF, Schwimmer JB; NASH CRN Research Group.

Am J Gastroenterol. 2011 Mar;106(3):460-8; quiz 469. doi: 10.1038/ajg.2010.488. Epub 2011 Jan 4.

18.

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients.

Noureddin M, Yates KP, Vaughn IA, Neuschwander-Tetri BA, Sanyal AJ, McCullough A, Merriman R, Hameed B, Doo E, Kleiner DE, Behling C, Loomba R; NASH CRN.

Hepatology. 2013 Nov;58(5):1644-54. doi: 10.1002/hep.26465. Epub 2013 Oct 2.

19.

Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.

Kodhelaj K, Resuli B, Petrela E, Malaj V, Jaze H.

Minerva Pediatr. 2014 Feb;66(1):23-30.

PMID:
24608579
20.

Alcohol consumption is associated with progression of hepatic fibrosis in non-alcoholic fatty liver disease.

Ekstedt M, Franzén LE, Holmqvist M, Bendtsen P, Mathiesen UL, Bodemar G, Kechagias S.

Scand J Gastroenterol. 2009;44(3):366-74. doi: 10.1080/00365520802555991.

PMID:
19016382

Supplemental Content

Support Center